Search research articles
Contact Us
Filters
Showing results (71-80 of 126) with videos related to
Page
of 13
Sort By:
Leukemia
|
May 1, 2020
Upregulation of CD38 expression on multiple myeloma cells by novel HDAC6 inhibitors is a class effect and augments the efficacy of daratumumab
Estefanía García-Guerrero, Ralph Götz, Sören Doose, et al.
Blood
|
March 6, 2010
Leukemia-associated minor histocompatibility antigen discovery using T-cell clones isolated by in vitro stimulation of naive CD8+ T cells
Marie Bleakley, Brith E Otterud, Julia L Richardt, et al.
Nature Immunology
|
July 8, 2020
Inefficient CAR-proximal signaling blunts antigen sensitivity
Venugopal Gudipati, Julian Rydzek, Iago Doel-Perez, et al.
Cell Stem Cell
|
May 16, 2024
Breast cancer-on-chip for patient-specific efficacy and safety testing of CAR-T cells
Tengku Ibrahim Maulana, Claudia Teufel, Madalena Cipriano, et al.
Journal of Immunotoxicology
|
December 10, 2024
Identifying CD19-targeted CAR-T cell immune pathways in an in vitro human immune mimetic cytokine release assay
Thuvan Dinh-Le, John Escobar, Louis Poisson, et al.
Frontiers in Immunology
|
December 11, 2023
Accelerating development of engineered T cell therapies in the EU: current regulatory framework for studying multiple product versions and T2EVOLVE recommendations
Delphine Ammar, Inga Schapitz, Maik Luu, et al.
Journal of Molecular Biology
|
August 19, 2017
Mining Naïve Rabbit Antibody Repertoires by Phage Display for Monoclonal Antibodies of Therapeutic Utility
Haiyong Peng, Thomas Nerreter, Jing Chang, et al.
Biotechnology Journal
|
September 9, 2025
Impact of Serum/Xeno-Free Medium and Cytokine Supplementation on CAR-T Cell Therapy Manufacturing in Stirred Tank Bioreactors
Pedro Silva Couto, Dale J Stibbs, Pierre Springuel, et al.
Blood
|
April 25, 2012
Cyclin-A1 represents a new immunogenic targetable antigen expressed in acute myeloid leukemia stem cells with characteristics of a cancer-testis antigen
Sebastian Ochsenreither, Ravindra Majeti, Thomas Schmitt, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
May 3, 2021
Composite CD79A/CD40 co-stimulatory endodomain enhances CD19CAR-T cell proliferation and survival
Jakrawadee Julamanee, Seitaro Terakura, Koji Umemura, et al.
Page
of 13
Search research articles
Search
Showing results (71-80 of 126) with videos related to
Sort By:
Page
of 13
Leukemia
|
May 1, 2020
Upregulation of CD38 expression on multiple myeloma cells by novel HDAC6 inhibitors is a class effect and augments the efficacy of daratumumab
Estefanía García-Guerrero, Ralph Götz, Sören Doose, et al.
Blood
|
March 6, 2010
Leukemia-associated minor histocompatibility antigen discovery using T-cell clones isolated by in vitro stimulation of naive CD8+ T cells
Marie Bleakley, Brith E Otterud, Julia L Richardt, et al.
Nature Immunology
|
July 8, 2020
Inefficient CAR-proximal signaling blunts antigen sensitivity
Venugopal Gudipati, Julian Rydzek, Iago Doel-Perez, et al.
Cell Stem Cell
|
May 16, 2024
Breast cancer-on-chip for patient-specific efficacy and safety testing of CAR-T cells
Tengku Ibrahim Maulana, Claudia Teufel, Madalena Cipriano, et al.
Journal of Immunotoxicology
|
December 10, 2024
Identifying CD19-targeted CAR-T cell immune pathways in an in vitro human immune mimetic cytokine release assay
Thuvan Dinh-Le, John Escobar, Louis Poisson, et al.
Frontiers in Immunology
|
December 11, 2023
Accelerating development of engineered T cell therapies in the EU: current regulatory framework for studying multiple product versions and T2EVOLVE recommendations
Delphine Ammar, Inga Schapitz, Maik Luu, et al.
Journal of Molecular Biology
|
August 19, 2017
Mining Naïve Rabbit Antibody Repertoires by Phage Display for Monoclonal Antibodies of Therapeutic Utility
Haiyong Peng, Thomas Nerreter, Jing Chang, et al.
Biotechnology Journal
|
September 9, 2025
Impact of Serum/Xeno-Free Medium and Cytokine Supplementation on CAR-T Cell Therapy Manufacturing in Stirred Tank Bioreactors
Pedro Silva Couto, Dale J Stibbs, Pierre Springuel, et al.
Blood
|
April 25, 2012
Cyclin-A1 represents a new immunogenic targetable antigen expressed in acute myeloid leukemia stem cells with characteristics of a cancer-testis antigen
Sebastian Ochsenreither, Ravindra Majeti, Thomas Schmitt, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
May 3, 2021
Composite CD79A/CD40 co-stimulatory endodomain enhances CD19CAR-T cell proliferation and survival
Jakrawadee Julamanee, Seitaro Terakura, Koji Umemura, et al.
Page
of 13